Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
5 hedge funds and large institutions have $9K invested in Artelo Biosciences, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
40% less capital invested
Capital invested by funds: $15K → $9K (-$6K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWMIA
Global Wealth Management Investment Advisory
Fort Lauderdale,
Florida
|
+$102 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$901 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Verition Fund Management
Greenwich,
Connecticut
| $6K | – | – | – |
|
|
AGM
2
Alpine Global Management
New York
| $3K | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$3K | -13,786 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$901 | -4,177 | -95% |
|
|
GWMIA
5
Global Wealth Management Investment Advisory
Fort Lauderdale,
Florida
| – | +$102 | +475 | New |
|
ARTLW Hedge Fund Activity: Q4 2021 in Review
5 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q4 2021, worth a combined $9K — down 40% from $15K a quarter earlier.
Fund positioning in ARTLW was balanced in Q4 2021: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Global Wealth Management Investment Advisory, opening a new position worth an estimated $102. The largest seller was Susquehanna International Group, exiting entirely with an estimated $3K sold.
- 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $9K of Artelo Biosciences, Inc. Warrant stock for Q4 2021, down 40% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q4 2021 and 1 closed out, a net change of 0 holders.
- The largest Artelo Biosciences, Inc. Warrant buyer in Q4 2021 was Global Wealth Management Investment Advisory, an estimated $102 added.
- The largest Artelo Biosciences, Inc. Warrant seller in Q4 2021 was Susquehanna International Group, an estimated $3K sold.
Based on aggregated 13F filings for Q4 2021.